HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lois E H Smith Selected Research

Proteins (Proteins, Gene)

4/2024Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants.
3/2016The Eyes Absent Proteins in Developmental and Pathological Angiogenesis.
6/2006Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lois E H Smith Research Topics

Disease

34Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2023 - 07/2003
21Pathologic Neovascularization
01/2020 - 01/2007
16Retinal Neovascularization
01/2023 - 07/2003
12Hypoxia (Hypoxemia)
01/2017 - 08/2005
10Premature Birth (Birth, Premature)
11/2022 - 11/2003
10Macular Degeneration (Age-Related Maculopathy)
01/2020 - 09/2010
8Choroidal Neovascularization
01/2022 - 01/2015
8Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021 - 01/2009
7Eye Diseases (Eye Disease)
01/2018 - 11/2011
5Inflammation (Inflammations)
04/2024 - 10/2012
5Neoplasms (Cancer)
06/2021 - 02/2011
5Ischemia
01/2016 - 07/2003
4Hyperglycemia
01/2023 - 01/2016
4Hyperoxia
11/2022 - 07/2003
4Birth Weight (Birth Weights)
10/2021 - 11/2003
4Blindness (Hysterical Blindness)
01/2020 - 01/2005
4Weight Gain
01/2017 - 12/2006
3Hemorrhage
01/2021 - 01/2016
2Ganglion Cysts (Ganglion)
05/2023 - 04/2009
2Brain Injuries (Brain Injury)
01/2020 - 01/2016
2Necrosis
01/2017 - 08/2010
2Vascular Diseases (Vascular Disease)
08/2012 - 02/2008
1Dyslipidemias (Dyslipidemia)
11/2022
1Neurodevelopmental Disorders
01/2022
1Retinitis Pigmentosa (Pigmentary Retinopathy)
11/2021
1Ocular Hypertension (Glaucoma, Suspect)
06/2021
1Uveitis
06/2021
1Neoplasm Metastasis (Metastasis)
06/2021
1Retinal Degeneration
04/2021
1Epiretinal Membrane (Epiretinal Membranes)
01/2021
1Optic Nerve Diseases (Optic Neuropathy)
01/2017
1Type 2 Diabetes Mellitus (MODY)
11/2016
1Retinal Diseases
04/2016
1Telangiectasis (Telangiectasia)
04/2016
1Neuroinflammatory Diseases
01/2016
1Necrotizing Enterocolitis
01/2016
1Bronchopulmonary Dysplasia
01/2016

Drug/Important Bio-Agent (IBA)

35Retinaldehyde (Retinal)IBA
05/2023 - 07/2003
24Oxygen (Dioxygen)IBA
11/2022 - 07/2003
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 07/2002
14Insulin-Like Growth Factor I (IGF-1)IBA
01/2021 - 11/2003
10Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2024 - 02/2011
9LipidsIBA
01/2021 - 02/2011
5Fatty Acids (Saturated Fatty Acids)IBA
04/2024 - 07/2007
5Insulin-Like PeptidesIBA
01/2021 - 05/2009
5ErythropoietinFDA Link
01/2019 - 02/2008
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2013 - 06/2006
4Arachidonic Acid (Vitamin F)IBA
04/2024 - 01/2018
4Messenger RNA (mRNA)IBA
01/2020 - 08/2005
3Docosahexaenoic AcidsIBA
04/2024 - 01/2021
3Proteins (Proteins, Gene)FDA Link
04/2024 - 06/2006
3fibroblast growth factor 21IBA
01/2023 - 01/2017
3Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2022 - 03/2014
3AdiponectinIBA
01/2017 - 04/2015
3cytochrome P-450 CYP2C subfamilyIBA
11/2016 - 03/2014
3Cytochrome P-450 CYP2C8IBA
11/2016 - 03/2014
3Insulin (Novolin)FDA Link
01/2014 - 06/2006
3Insulin-Like Growth Factor Binding Protein 3IBA
01/2013 - 12/2006
2Interleukin-6 (Interleukin 6)IBA
04/2024 - 01/2020
2CytokinesIBA
04/2024 - 10/2012
2Oxidoreductases (Dehydrogenase)IBA
01/2022 - 01/2016
2Carrier Proteins (Binding Protein)IBA
01/2021 - 01/2019
2VLDL LipoproteinsIBA
01/2017 - 04/2011
219,20-epoxydocosapentaenoic acidIBA
11/2016 - 03/2014
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2015 - 07/2003
2Sirtuin 1IBA
01/2014 - 10/2013
2PPAR gammaIBA
01/2013 - 08/2010
1ProteomeIBA
04/2024
1Sphingosine-1-Phosphate ReceptorsIBA
01/2023
1ORALIT (ORS)IBA
10/2021
1SteroidsIBA
06/2021
1Neuroprotective AgentsIBA
04/2021
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2021
1CreatineIBA
01/2021
1Phosphotransferases (Kinase)IBA
01/2020
1FructoseIBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2020
1cupric sulfide (CuS)IBA
01/2020
1PF-05231023IBA
01/2018
1Ranibizumab (Lucentis)FDA Link
01/2018
1EmulsionsIBA
08/2017
1Fish OilsIBA
08/2017
1Hemoglobins (Hemoglobin)IBA
06/2017
1G-Protein-Coupled Receptor Kinase 1 (G Protein-Coupled Receptor Kinase 1)IBA
01/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2016
1Fenofibrate (CiL)FDA LinkGeneric
11/2016
1Glucose (Dextrose)FDA LinkGeneric
04/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2016
1Tyrosine (L-Tyrosine)FDA Link
03/2016
1montelukast (Singulair)FDA Link
01/2016
1LigandsIBA
10/2015
1Methionine (L-Methionine)FDA Link
10/2015
1phosducinIBA
10/2015

Therapy/Procedure

7Therapeutics
06/2021 - 06/2010
7Lasers (Laser)
01/2020 - 04/2009
3Aftercare (After-Treatment)
06/2021 - 01/2005
2Parenteral Nutrition
01/2023 - 01/2017
1Rehabilitation
01/2022
1Radiotherapy
06/2021
1Drug Therapy (Chemotherapy)
06/2021